Primary-Site Local Therapy for Patients with De Novo Metastatic Breast Cancer: An Educational Review.
Seema Ahsan KhanSteven SchuetzOmid HosseiniPublished in: Annals of surgical oncology (2022)
The current evidence fails to refute the 20th century paradigm guiding management of de novo metastatic breast cancer. Discussion continues regarding the survival value of PSLT for patients with bone-only disease or oligometastases, but unbiased evidence is lacking.